State-dependent inhibition of Na+ currents by the neuroprotective agent 619C89 in rat hippocampal neurons and in a mammalian cell line expressing rat brain type IIA Na+ channels.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neuroscience

• Publication date

  1996-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0306-4522(96)00092-9PMID 8809814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones

  1995cited by this paper
• Cerebroprotective effect of lamotrigine after focal ischemia in rats.

  1995cited by this paper
• Clinical experience with excitatory amino acid antagonist drugs.

  1995cited by this paper
• Na+ channels as targets for neuroprotective drugs.

  1995cited by this paper
• Neuroprotective Effects of Tetrodotoxin as a Na+ Channel Modulator and Glutamate Release Inhibitor in Cultured Rat Cerebellar Neurons and in Gerbil Global Brain Ischemia

  1994cited by this paper
• Role of Angiotensin Receptor Subtypes in the Response of Rabbit Brain Arterioles to Angiotensin

  1994cited by this paper
• Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms.

  1994cited by this paper
• Molecular mechanisms of inactivation and modulation of sodium channels.

  1994cited by this paper
• Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.

  1994cited by this paper
• Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats.

  1994cited by this paper
• The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum.

  1994cited by this paper
• The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study.

  1993cited by this paper
• Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat.

  1993cited by this paper
• Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.

  1993cited by this paper
• Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase.

  1993cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Na+ currents that fail to inactivate

  1993cited by this paper
• BW619C89, a Glutamate Release Inhibitor, Protects Against Focal Cerebral Ischemic Damage

  1993cited by this paper
• Steady-state availability of sodium channels. Interactions between activation and slow inactivation.

  1992cited by this paper
• Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger

  1992cited by this paper
• Cellular and molecular biology of voltage-gated sodium channels.

  1992cited by this paper
• Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain.

  1992cited by this paper
• Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87.

  1992cited by this paper
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

  1991cited by this paper
• Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.

  1991cited by this paper
• Neurochemical and Behavioral Aspects of Lamotrigine

  1991cited by this paper
• Functional properties of rat brain sodium channels expressed in a somatic cell line.

  1990cited by this paper
• Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons.

  1989cited by this paper
• Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells.

  1984cited by this paper
• Lidocaine block of cardiac sodium channels

  1983cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA.

  1975cited by this paper
• The Inhibition of Sodium Currents in Myelinated Nerve by Quaternary Derivatives of Lidocaine

  1973cited by this paper

• Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092

  2021cites this paper
• Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism

  2021cites this paper
• Modulation of fast-spiking interneurons using two-pore channel blockers

  2018cites this paper
• Alpha2-adrenoceptor-independent inhibition of acetylcholine receptor channel and sodium channel by dexmedetomidine in rat superior cervical ganglion neurons.

  2015cites this paper
• Sodium channels, inherited epilepsy, and antiepileptic drugs.

  2014cites this paper
• Dibenzazepine‐Based Sodium Channel Blockers for the Treatment of Neuropathic Pain

  2013cites this paper
• Molecular Model of Anticonvulsant Drug Binding to the Voltage-Gated Sodium Channel Inner Pore

  2010cites this paper
• Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.

  2009cites this paper
• Validation of High Throughput Screening Assays Against Three Subtypes of Cav3 T-Type Channels Using Molecular and Pharmacologic Approaches

  2007cites this paper
• X-ray Crystallographic Structures of Neuroprotective Pyrimidine Derivatives: (I) the Mesylate Salt of BW1003C87 and (II) Sipatrigine Base

  2007cites this paper
• Lamotrigine dimethyl­formamide sesquisolvate

  2006cites this paper
• A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain

  2006cites this paper
• Sipatrigine (BW 619C89) is a Neuroprotective Agent and a Sodium Channel and Calcium Channel Inhibitor

  2006cites this paper
• The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential

  2005cites this paper
• Neuroprotection — rationale for pharmacological modulation of Na+-channels

  2005cites this paper
• Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels.

  2003cites this paper
• Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition.

  2002cites this paper
• Role of Amino Acid Residues in Transmembrane Segments IS6 and IIS6 of the Na+ Channel α Subunit in Voltage-dependent Gating and Drug Block*

  2002cites this paper
• Molecular and Cellular Biology of Neuroprotection in the CNS

  2002cites this paper
• Na+ channels and Ca2+ channels of the cell membrane as targets of neuroprotective substances.

  2002cites this paper
• An acute experimental model of hearing loss using noise in combination with hypoxia and its use in the investigation of a putative cochleoprotectant

  2002cites this paper
• The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons.

  2001cites this paper
• Identification of a novel voltage-gated Na+ channel rNav1.5a in the rat hippocampal progenitor stem cell line HiB5

  2001influential citation
• Molecular Determinants of Voltage-dependent Gating and Binding of Pore-blocking Drugs in Transmembrane Segment IIIS6 of the Na+ Channel α Subunit*

  2001cites this paper
• Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex.

  2001cites this paper
• The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK.

  2001cites this paper
• Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92.

  2001cites this paper
• Inhibition of recombinant low-voltage-activated Ca(2+) channels by the neuroprotective agent BW619C89 (Sipatrigine).

  2000cites this paper
• Inhibitory Action Of Ambocarb On Voltage‐Operated Sodium Channels In Rat Isolated Hippocampal Pyramidal Neurons

  2000cites this paper
• Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects.

  2000cites this paper
• Is pharmacological neuroprotection dependent on reduced glutamate release?

  2000cites this paper
• Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL.

  2000cites this paper
• BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.

  1999cites this paper
• Mechanisms of ischaemic damage to central white matter axons: a quantitative histological analysis using rat optic nerve.

  1999cites this paper
• Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability

  1999cites this paper
• Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.

  1999cites this paper
• On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89

  1998cites this paper
• Voltage- and use-dependent inhibition of Na + channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent

  1998cites this paper
• Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

  1998cites this paper
• Voltage‐ and use‐dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent

  1998cites this paper
• Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder

  1998cites this paper
• Neuroprotective compounds inhibit depolarisation‐evoked calcium transients in granule cells

  1998cites this paper
• Inhibition of human N-type voltage-gated Ca2+ channels by the neuroprotective agent BW619C89.

  1997cites this paper
• Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies.

  1997cites this paper
• A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia.

  1995cites this paper
• Highlights of the Society for Medicines Research Symposium held on September 27 , 2001 , in London . The Role of Sodium Channels in Disease Summary

  year unknowncites this paper